Long Beach Memorial Pathology Medical Group, INC.

Long Beach Memorial Pathology Medical Group, INC. was paid $7.94M by Medicaid between Jan 2018 and Dec 2024, across 250 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 17% of everything it billed.

33Billing provider infoLONG BEACH MEMORIAL PATHOLOGY MEDICAL GROUP, INC.
LONG BEACH, CA 90806

33aNPI1942257191assigned 05/30/2006

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$7.94M

24GClaims3,353,603

24DCodes billed250

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#3 of 222

Median peer was paid$42K

This provider vs. median188×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	470,768	$825K
2019	434,506	$984K
2020	387,770	$1.12M
2021	517,436	$1.39M
2022	463,653	$1.16M
2023	614,922	$1.53M
2024incomplete	464,548	$934K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88305	Level IV - Surgical pathology, gross and microscopic examination	17%	33,128	32,165	$1.36M
88307		8.3%	12,049	11,915	$655K
80053	Comprehensive metabolic panel	7.4%	271,836	162,015	$589K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	4.9%	26,292	24,161	$387K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.6%	361,577	192,700	$369K
80048	Basic metabolic panel (calcium, ionized)	4.2%	248,252	96,344	$333K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.8%	6,502	6,283	$219K
88312		2.3%	9,358	9,239	$182K
83735		2.2%	169,522	45,926	$174K
87507		2.0%	1,519	1,472	$158K
88304		1.9%	9,067	9,009	$154K
83880		1.8%	29,174	24,539	$144K

238 more codes

U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.7%	8,711	$138K
85027		1.7%	133,222	$137K
82962		1.7%	44,001	$134K
80074		1.6%	27,109	$125K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	1.5%	8,450	$119K
84145		1.3%	28,404	$100K
88342		1.2%	3,898	$97K
82803		1.1%	34,311	$87K
87040		1.1%	39,689	$84K
84100		1.0%	126,072	$81K
85730		<1%	87,791	$78K
83690		<1%	78,253	$69K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	6,556	$69K
83605		<1%	40,183	$69K
80076		<1%	62,341	$64K
81001		<1%	111,835	$62K
85610		<1%	99,460	$57K
86923		<1%	9,835	$56K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	3,033	$50K
87086	Culture, bacterial; quantitative colony count, urine	<1%	49,734	$49K
85060		<1%	5,258	$49K
84484		<1%	30,717	$46K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	10,937	$45K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	16,983	$45K
84443	Thyroid stimulating hormone (TSH)	<1%	23,047	$44K
81025		<1%	32,542	$37K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	4,748	$35K
80061	Lipid panel	<1%	14,784	$34K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	8,310	$33K
82947		<1%	30,041	$33K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	8,329	$32K
80047		<1%	28,061	$31K
87077		<1%	20,112	$30K
86901		<1%	72,977	$29K
86900		<1%	71,224	$29K
83036	Hemoglobin; glycosylated (A1C)	<1%	23,224	$29K
87081		<1%	25,210	$28K
85007		<1%	59,923	$27K
84703		<1%	35,666	$27K
88341		<1%	911	$26K
86140		<1%	30,384	$24K
87186		<1%	18,533	$23K
84702		<1%	16,223	$23K
85379		<1%	15,390	$23K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	7,723	$23K
81003		<1%	45,791	$21K
85520		<1%	11,681	$21K
82330		<1%	11,439	$19K
86850		<1%	41,535	$18K
86780		<1%	11,809	$18K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,248	$17K
88112		<1%	1,314	$17K
87070		<1%	14,862	$16K
87390		<1%	7,654	$15K
80320		<1%	5,909	$15K
80202		<1%	7,297	$15K
82550		<1%	16,271	$14K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,648	$14K
85384		<1%	10,909	$14K
88108		<1%	707	$13K
82728		<1%	8,326	$13K
80306		<1%	2,191	$13K
84156		<1%	7,589	$13K
82140		<1%	6,087	$12K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,842	$12K
80329		<1%	3,204	$12K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,180	$11K
83615		<1%	13,911	$10K
84478		<1%	18,206	$10K
83540		<1%	6,363	$9K
84439		<1%	6,933	$9K
87205		<1%	13,168	$9K
86592		<1%	14,477	$8K
86880		<1%	10,418	$8K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,796	$8K
86762		<1%	5,362	$7K
86703		<1%	6,141	$7K
87653		<1%	1,990	$7K
83498		<1%	2,619	$7K
87075		<1%	5,379	$7K
87154		<1%	95	$7K
87340		<1%	5,467	$7K
82746		<1%	3,453	$7K
88302		<1%	343	$7K
85014		<1%	16,507	$6K
82607		<1%	3,875	$6K
82105		<1%	1,398	$6K
87088		<1%	7,168	$6K
82010		<1%	4,601	$6K
87147		<1%	7,441	$6K
82533		<1%	1,956	$6K
82570		<1%	8,023	$5K
88300		<1%	1,093	$5K
83021		<1%	2,753	$5K
85652		<1%	13,433	$5K
84300		<1%	5,464	$5K
82248		<1%	7,669	$5K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	162	$5K
83789		<1%	2,586	$5K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,039	$4K
84550		<1%	7,664	$4K
82261		<1%	2,590	$4K
83516		<1%	3,740	$4K
87808		<1%	3,482	$4K
82150		<1%	3,646	$4K
84481		<1%	1,940	$4K
87210		<1%	6,411	$4K
87149		<1%	165	$4K
82247		<1%	6,815	$3K
83550		<1%	3,483	$3K
83874		<1%	1,556	$3K
84466		<1%	1,392	$3K
84450		<1%	5,894	$3K
87631		<1%	325	$3K
82785		<1%	1,611	$3K
82378		<1%	1,250	$3K
87632		<1%	118	$3K
84460		<1%	5,988	$3K
82776		<1%	2,605	$3K
82274		<1%	758	$3K
86870		<1%	1,017	$3K
86803		<1%	1,409	$3K
83970		<1%	473	$3K
87449		<1%	1,512	$2K
85018		<1%	6,602	$2K
83935		<1%	1,588	$2K
87503		<1%	421	$2K
86038		<1%	1,181	$2K
83930		<1%	1,888	$2K
85362		<1%	1,178	$2K
82565		<1%	2,931	$2K
87106		<1%	838	$2K
82945		<1%	2,183	$2K
84132		<1%	3,744	$2K
83090		<1%	706	$2K
82784		<1%	1,954	$1K
86160		<1%	929	$1K
88333		<1%	76	$1K
82040		<1%	3,681	$1K
84075		<1%	3,647	$1K
88360		<1%	41	$1K
87076		<1%	1,119	$1K
84540		<1%	1,515	$1K
88311		<1%	367	$1K
85049		<1%	2,523	$1K
87206		<1%	1,793	$1K
83010		<1%	809	$1K
85045		<1%	1,846	$1K
82950		<1%	1,353	$1K
87102		<1%	793	$988.61
89051		<1%	283	$964.24
84295		<1%	2,145	$945.65
84157		<1%	2,181	$936.47
86301		<1%	338	$888.14
85347		<1%	619	$849.71
86706		<1%	627	$790.63
86922		<1%	69	$724.83
84436		<1%	1,053	$720.87
84112		<1%	273	$671.55
86141		<1%	336	$603.66
84133		<1%	873	$598.45
81000		<1%	1,543	$576.42
88313		<1%	14	$544.01
84134		<1%	288	$519.45
83630		<1%	48	$513.95
86920		<1%	396	$503.96
87496		<1%	129	$499.84
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	16	$494.62
88189		<1%	13	$473.89
82805		<1%	101	$472.83
87522	Neg quan hep c or qual rna	<1%	74	$470.46
82436		<1%	615	$457.34
82553		<1%	237	$454.17
86039		<1%	350	$440.50
82731		<1%	53	$438.31
87116		<1%	215	$393.00
87324		<1%	380	$385.61
85380		<1%	581	$373.03
86308		<1%	453	$356.87
81479	Unlisted molecular pathology procedure	<1%	300	$341.61
82375		<1%	169	$335.05
86304		<1%	122	$290.88
87581		<1%	70	$290.33
86147		<1%	97	$289.44
87486		<1%	71	$281.20
82977		<1%	426	$268.07
82310		<1%	503	$266.77
84160		<1%	252	$260.45
86905		<1%	133	$256.92
86225		<1%	165	$245.14
84681		<1%	99	$241.11
88173		<1%	12	$219.50
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	207	$215.23
83050		<1%	169	$195.65
86376		<1%	133	$186.93
87181		<1%	245	$169.11
88142		<1%	14	$167.14
87400		<1%	263	$160.65
84165		<1%	114	$149.07
87541		<1%	30	$133.63
86480		<1%	19	$132.87
86481		<1%	13	$111.40
85335		<1%	75	$103.00
86360		<1%	12	$82.26
87430		<1%	151	$81.12
82043		<1%	131	$78.75
87185		<1%	377	$77.06
86359		<1%	12	$72.79
86663		<1%	57	$71.93
88331		<1%	13	$71.24
85461		<1%	122	$68.03
80164		<1%	37	$67.26
81002		<1%	242	$56.91
82272		<1%	58	$56.43
82164		<1%	28	$55.43
87015		<1%	81	$52.81
87899		<1%	51	$50.72
80051		<1%	70	$41.18
88363		<1%	12	$36.29
86635		<1%	12	$34.60
82951		<1%	16	$32.53
86704		<1%	26	$29.82
86337		<1%	12	$26.43
84520		<1%	39	$25.48
86060		<1%	26	$23.56
80185		<1%	18	$20.09
87184		<1%	39	$16.96
85306		<1%	12	$16.02
83986		<1%	26	$15.07
86800		<1%	12	$13.95
87045		<1%	13	$12.75
Q0114	Fern test	<1%	14	$10.59
87176		<1%	12	$9.20
82952		<1%	14	$8.74
82810		<1%	13	$8.72
84403		<1%	45	$8.20
87420		<1%	29	$7.06
82042		<1%	14	$6.10

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSHANE, LISA (VICE PRES. TREASURER)